RxDoctor Payments Data

Margaret Redfield, MD

Advanced Heart Failure and Transplant Cardiology · Rochester, MNNPI 1114999265

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $443 of the $564 with a category attached, or 78.6%. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in MN, where the typical reported total is $1,560.

$564in general payments, 2019–2025

Across 5 payments — averaging $112.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis Pharma AG$284
  • Abbott$280
$217,582in research payments, 2019–2025

Across 52 payments — averaging $4184.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$145K
  • American Regent$37K
  • Medtronic$35K

What the payments were for

  • Travel & lodging$12121%
  • Food & beverage$44379%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis Pharma AG3$284
Abbott2$280

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$564 in reported general payments places this provider in the 40th percentile of 32 advanced heart failure and transplant cardiology providers in Minnesota.

See all advanced heart failure and transplant cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$11,008
Medicare patients
60
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol113$122,536
EntrestoSacubitril/Valsartan76$96,168
EliquisApixaban25$24,427
JardianceEmpagliflozin16$21,836
Eplerenone25$2,921
Metoprolol Succinate82$2,682
Atorvastatin Calcium29$566
Valsartan11$513
Losartan Potassium22$438
Ezetimibe15$346
Furosemide32$331
Carvedilol30$310
Levothyroxine Sodium13$242
Torsemide18$222
Spironolactone23$183

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →